LV10283B - Process for the manufacture of budesonide - Google Patents

Process for the manufacture of budesonide

Info

Publication number
LV10283B
LV10283B LVP-93-858A LV930858A LV10283B LV 10283 B LV10283 B LV 10283B LV 930858 A LV930858 A LV 930858A LV 10283 B LV10283 B LV 10283B
Authority
LV
Latvia
Prior art keywords
alpha
manufacture
budesonide
diene
beta
Prior art date
Application number
LVP-93-858A
Other versions
LV10283A (en
Inventor
Robert Gerrit Hofstraat
Petrus Hendricus Raijmakers
Pieter Vrijhof
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10283A publication Critical patent/LV10283A/en
Publication of LV10283B publication Critical patent/LV10283B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Paper (AREA)
  • Load-Bearing And Curtain Walls (AREA)

Abstract

The present invention relates to a novel process for the manufacture of (22 R,S)-16 alpha , 17 alpha -butylidenedioxy-11 beta , 21-dihydroxypregna-1,4-diene-3,20 dione (I) by reacting 11 beta , 16 alpha , 17 alpha 21-tetrahydroxypregna-1,4-diene (II) with butanal, CH3-CH2-CH2-CHO, in acetonitrile in presence of p-toluenesulphonic acid as a catalyst.
LVP-93-858A 1989-10-02 1993-06-30 Process for the manufacture of budesonide LV10283B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903219A SE8903219D0 (en) 1989-10-02 1989-10-02 PROCESS FOR THE MANUFACTURE OF BUDESONIDE
PCT/SE1990/000619 WO1991004984A1 (en) 1989-10-02 1990-09-27 Process for the manufacture of budesonide

Publications (2)

Publication Number Publication Date
LV10283A LV10283A (en) 1994-10-20
LV10283B true LV10283B (en) 1995-04-20

Family

ID=20377019

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-858A LV10283B (en) 1989-10-02 1993-06-30 Process for the manufacture of budesonide

Country Status (25)

Country Link
US (1) US5556964A (en)
EP (1) EP0494942B1 (en)
JP (1) JP2965352B2 (en)
KR (1) KR0160527B1 (en)
AT (1) ATE130310T1 (en)
AU (1) AU632864B2 (en)
BG (1) BG61608B1 (en)
BR (1) BR9007700A (en)
CA (1) CA2065861C (en)
CY (1) CY2084B1 (en)
DE (1) DE69023664T2 (en)
DK (1) DK0494942T3 (en)
ES (1) ES2079491T3 (en)
FI (1) FI103204B1 (en)
HK (1) HK52097A (en)
HU (1) HU212576B (en)
LT (1) LT3697B (en)
LV (1) LV10283B (en)
NO (1) NO178827C (en)
RO (1) RO110947B1 (en)
RU (1) RU2048472C1 (en)
SE (1) SE8903219D0 (en)
SG (1) SG43344A1 (en)
UA (1) UA26860C2 (en)
WO (1) WO1991004984A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
IT1291288B1 (en) 1997-04-30 1999-01-07 Farmabios Srl PROCESS FOR THE PREPARATION OF 16,17 ACETALS OF PREGNAN DERIVATIVES WITH CONTROL OF THE EPIMERICAL DISTRIBUTION AT C-22.
SE9704186D0 (en) 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6266556B1 (en) 1998-04-27 2001-07-24 Beth Israel Deaconess Medical Center, Inc. Method and apparatus for recording an electroencephalogram during transcranial magnetic stimulation
FR2782823B1 (en) 1998-09-01 2000-11-17 Neopost Ind THERMAL PRINTING PROCESS
US6234167B1 (en) 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
US6681998B2 (en) 2000-12-22 2004-01-27 Chrysalis Technologies Incorporated Aerosol generator having inductive heater and method of use thereof
US6799572B2 (en) 2000-12-22 2004-10-05 Chrysalis Technologies Incorporated Disposable aerosol generator system and methods for administering the aerosol
US6491233B2 (en) 2000-12-22 2002-12-10 Chrysalis Technologies Incorporated Vapor driven aerosol generator and method of use thereof
US6501052B2 (en) 2000-12-22 2002-12-31 Chrysalis Technologies Incorporated Aerosol generator having multiple heating zones and methods of use thereof
US6701921B2 (en) 2000-12-22 2004-03-09 Chrysalis Technologies Incorporated Aerosol generator having heater in multilayered composite and method of use thereof
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6640050B2 (en) 2001-09-21 2003-10-28 Chrysalis Technologies Incorporated Fluid vaporizing device having controlled temperature profile heater/capillary tube
US6568390B2 (en) 2001-09-21 2003-05-27 Chrysalis Technologies Incorporated Dual capillary fluid vaporizing device
US6804458B2 (en) 2001-12-06 2004-10-12 Chrysalis Technologies Incorporated Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
US6681769B2 (en) 2001-12-06 2004-01-27 Crysalis Technologies Incorporated Aerosol generator having a multiple path heater arrangement and method of use thereof
US6701922B2 (en) 2001-12-20 2004-03-09 Chrysalis Technologies Incorporated Mouthpiece entrainment airflow control for aerosol generators
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
ATE446581T1 (en) * 2004-03-12 2009-11-15 Trinity College Dublin MAGNETORRESISTIVE MEDIUM
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
EP1993598A2 (en) * 2006-02-15 2008-11-26 Tika Läkemedel AB Methods of manufacturing corticosteroid solutions
CN102060906B (en) * 2010-12-23 2013-01-16 鲁南贝特制药有限公司 Preparation method of R budesonide
US10233210B2 (en) * 2015-01-30 2019-03-19 Coral Drugs Pvt. Ltd. Process for preparation of glucocorticoid steroids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197469A (en) * 1958-08-06 1965-07-27 Pharmaceutical Res Products In 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
US3077471A (en) * 1961-08-04 1963-02-12 Olin Mathieson Steroids of the 19-norpregnane series
SE378109B (en) * 1972-05-19 1975-08-18 Bofors Ab
SE8008524L (en) * 1980-12-04 1982-06-05 Draco Ab 4-PREGNEN DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION, PREPARATION AND METHOD OF TREATMENT OF INFLAMMATORY CONDITIONS
IT1196142B (en) * 1984-06-11 1988-11-10 Sicor Spa PROCEDURE FOR THE PREPARATION OF 16.17-ACETALS OF PREGNANIC DERIVATIVES AND NEW COMPOUNDS OBTAINED
SE8604059D0 (en) * 1986-09-25 1986-09-25 Astra Pharma Prod A METHOD OF CONTROLLING THE EPIMERIC DISTRIBUTION IN THE PREPARATION OF 16,17-ACETALS OF PREGNANE DERIVATIVES

Also Published As

Publication number Publication date
AU632864B2 (en) 1993-01-14
SG43344A1 (en) 1997-10-17
RO110947B1 (en) 1996-05-30
SE8903219D0 (en) 1989-10-02
DE69023664D1 (en) 1995-12-21
BR9007700A (en) 1992-08-11
CY2084B1 (en) 1998-10-16
RU2048472C1 (en) 1995-11-20
NO921233L (en) 1992-03-30
EP0494942B1 (en) 1995-11-15
HU212576B (en) 1996-08-29
US5556964A (en) 1996-09-17
ES2079491T3 (en) 1996-01-16
BG61608B1 (en) 1998-01-30
EP0494942A1 (en) 1992-07-22
JPH05500669A (en) 1993-02-12
DE69023664T2 (en) 1996-05-02
ATE130310T1 (en) 1995-12-15
LTIP1729A (en) 1995-07-25
HU9201064D0 (en) 1992-06-29
NO178827C (en) 1996-06-12
CA2065861C (en) 2001-06-05
NO178827B (en) 1996-03-04
KR0160527B1 (en) 1998-11-16
FI103204B (en) 1999-05-14
LT3697B (en) 1996-02-26
JP2965352B2 (en) 1999-10-18
LV10283A (en) 1994-10-20
HK52097A (en) 1997-05-02
WO1991004984A1 (en) 1991-04-18
HUT60281A (en) 1992-08-28
FI921426A (en) 1992-04-01
UA26860C2 (en) 1999-12-29
AU6530990A (en) 1991-04-28
FI103204B1 (en) 1999-05-14
FI921426A0 (en) 1992-04-01
NO921233D0 (en) 1992-03-30
CA2065861A1 (en) 1991-04-03
DK0494942T3 (en) 1996-03-11
BG96166A (en) 1993-12-24

Similar Documents

Publication Publication Date Title
CY2084B1 (en) Process for the manufacture of budesonide
ES8705462A1 (en) A process for the preparation of 16,17 acetals of pregnane derivatives and compounds obtained therefrom.
GR1001529B (en) Process for the obtainment of a new pregna-1,4-diene-3,20-dione -16-17-acetal-21 esters
JPS57203097A (en) Manufacture of high purity ulsodeoxycholic acid
Boeckman Jr et al. Synthesis and reactivity of endocyclic α, β-epoxy-γ-butyrolactones
US2666072A (en) Halogenation and oxidation of steroids
EP0335106A3 (en) Novel intermediates and an improved process for producing the compound (3 beta, 5 alpha)-3-hydroxycholest-8(14)-en-15-one
GB1292846A (en) A process for the synthesis of leupeptins and their analogues
DE1096353B (en) Process for the preparation of 1,2-methylene-3-ketosteroids
ES8702876A1 (en) Process for the preparation of monochloroacetic acid from glycolic acid.
GB970482A (en) New 17-desoxy corticosteroids and processes for their preparation
DD274031A1 (en) PROCESS FOR PREPARING 3-SUBSTITUTED 5GAMMA HYDROXY-6BETA-FLUOR-1-EN-STEROIDS
DE1912794A1 (en) Process for the preparation of halohydrins